Learning about treatment effects in a new target population under transportability assumptions for relative effect measures
- 10 May 2024
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 39 (9) , 957-965
Abstract
Investigators often believe that relative effect measures conditional on covariates, such as risk ratios and mean ratios, are “transportable” across populations. Here, we examine the identification of causal effects in a target population using an assumption that conditional relative effect measures are transportable from a trial to the target population. We show that transportability for relative effect measures is largely incompatible with transportability for difference effect measures, unless the treatment has no effect on average or one is willing to make even stronger transportability assumptions that imply the transportability of both relative and difference effect measures. We then describe how marginal (population-averaged) causal estimands in a target population can be identified under the assumption of transportability of relative effect measures, when we are interested in the effectiveness of a new experimental treatment in a target population where the only treatment in use is the control treatment evaluated in the trial. We extend these results to consider cases where the control treatment evaluated in the trial is only one of the treatments in use in the target population, under an additional partial exchangeability assumption in the target population (i.e., an assumption of no unmeasured confounding in the target population with respect to potential outcomes under the control treatment in the trial). We also develop identification results that allow for the covariates needed for transportability of relative effect measures to be only a small subset of the covariates needed to control confounding in the target population. Last, we propose estimators that can be easily implemented in standard statistical software and illustrate their use using data from a comprehensive cohort study of stable ischemic heart disease.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Comparison of Methods to Generalize Randomized Clinical Trial Results Without Individual-Level Data for the Target PopulationAmerican Journal of Epidemiology, 2019
- Robust Estimation of Encouragement Design Intervention Effects Transported Across SitesJournal of the Royal Statistical Society Series B: Statistical Methodology, 2016
- Diagnosing and responding to violations in the positivity assumptionStatistical Methods in Medical Research, 2010
- Generalizing Evidence From Randomized Clinical Trials to Target Populations: The ACTG 320 TrialAmerican Journal of Epidemiology, 2010
- Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risksBMJ, 2006
- Interval estimation by simulation as an alternative to and extension of confidence intervalsInternational Journal of Epidemiology, 2004
- TOWARD A CURSE OF DIMENSIONALITY APPROPRIATE (CODA) ASYMPTOTIC THEORY FOR SEMI‐PARAMETRIC MODELSStatistics in Medicine, 1997
- An evidence based approach to individualising treatmentBMJ, 1995
- Interpretation and estimation of summary ratios under heterogeneityStatistics in Medicine, 1982
- STANDARDIZATION OF RISK RATIOSAmerican Journal of Epidemiology, 1972